APA Citation

Onea, A. S., & Jazirehi, A. R. (2016). CD19 chimeric antigen receptor (CD19 CAR)-redirected adoptive T-cell immunotherapy for the treatment of relapsed or refractory B-cell Non-Hodgkin’s Lymphomas. Am J Cancer Res.

Citação norma Chicago

Onea, Alexandra S., and Ali R. Jazirehi. "CD19 Chimeric Antigen Receptor (CD19 CAR)-redirected Adoptive T-cell Immunotherapy for the Treatment of Relapsed or Refractory B-cell Non-Hodgkin’s Lymphomas." Am J Cancer Res 2016.

MLA Citation

Onea, Alexandra S., and Ali R. Jazirehi. "CD19 Chimeric Antigen Receptor (CD19 CAR)-redirected Adoptive T-cell Immunotherapy for the Treatment of Relapsed or Refractory B-cell Non-Hodgkin’s Lymphomas." Am J Cancer Res 2016.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.